VJOncology is committed to improving our service to you

Share this video  

VJOncology is committed to improving our service to you

EAU 2020 | PREFERE: active surveillance in prostate cancer

Peter Albers, MD, University Hospital of Düsseldorf, Düsseldorf, Germany, describes the results of the PREFERE trial (NCT01717677), evaluating active surveillance in low- and early intermediate-risk prostate cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter